GenAIoT Panel – The confluence of Generative AI and the IoT – or GenAIoT

Session Abstract:

The confluence of Generative AI and the IoT – or GenAIoT, continues to develop, affording many business and societal benefits. Such as increased efficiency and cost savings as AI can analyze data from IoT sensors to predict equipment failures and schedule maintenance proactively, minimizing downtime and maintenance costs. And, AI automated operations and decision-making, based on data analysis, optimizing processes across various industries. To highlight the state of the art and the future outlook, Dr. Tom Bradicich, IoT Community Board Chair, will moderate a panel featuring edge, IoT, and AI industry experts. Join us to hear real-world use cases, challenges, and opportunities in this high growth multi-billion dollar market.

Speakers:

Austin McMillan is a Business Development Specialist within the SAS Industrials & IoT division, where he focuses on developing strategic IoT and AI ecosystem partnerships. He is passionate about empowering companies that make, move, and grow to launch their strategic connected initiatives. Austin brings extensive applied AI experience across technologies such as Natural Language Processing (NLP), Computer Vision, IoT, and Machine Learning, spanning diverse industries including Tier-1 automotive, aerospace, mining, and transportation/logistics.

Dr. Tom Bradicich, Chairman of the IoT Community Board of Advisors, began his career at IBM, where he was an IBM Fellow, R&D VP, Distinguish Engineer, and Server CTO. At National Instruments, an Operational Technologies (OT) company, he served as an NI Fellow and company officer, pioneering Big Analog Data™ solutions. While at HP and Hewlett Packard Enterprise (HPE), Tom held various roles including R&D VP, HPE Fellow, Global Head of Edge & IoT Software Labs, and General Manager, As GM, he lead the global business unit, Servers and Edge Systems and Software, with P&L, worldwide sales, R&D, and customer experience ownership. Opening three global Innovation Labs, and exceeding salsas quotes by achieving revenue growth of over $250M, Tom’s business unit was the fastest growing in HPE. Tom and his team developed and launched dozens of systems and software products, such as advanced as-a-Service (aaS) software for cloud managed remote infrastructure, edge-as-a-service, and converged IT/Operational Technologies (OT). And the creation of several new product categories such as notebook computers, smartphones (IBM Simon™), Converged Systems (IBM BladeCenter™), Converged Edge Systems & Sofware (HPE Edgeline™), and OT and edge management software and platforms (HPE OTLink). Tom’s teams designed and launched the first 64 bit enterprise ARM server, the first x86 server with on-chip graphics, and IBM’s first prototype notebook computer. He incepted and directed the HPE Channel-to-Edge Institute partner program, and led company-wide strategies and venture/M&A assessments, and led HPE’s first corporate IoT & edge strategy. Tom is named in CRN’s Top 100 Executives and Top 25 Disrupters for three years, inducted into the NC State University Alumni Hall of Fame, received the IBM Chairman’s Award, and elected to the IBM Academy of Technology. He served on the Board of Directors of Aspen Technology (AZPN), a publicly traded Industrial AI software company, the Board of Advisors of SparkCognition, an AI software company, and the Board of Advisors and Diversity Committee, University of Florida. Tom holds several US patents, and founded the charity sockrelief.com, providing socks to the homeless and children in need.

Eystein Stenberg is the CTO of NorthernTech, a leader in device lifecycle management, and the creator of Mender, the market-leading solution for robust, secure, and customizable over-the-air (OTA) software updates. With over 15 years of experience in security and systems management, Stenberg has served on the frontlines of some of the largest production environments and possesses in-depth knowledge on solving real-world system security challenges. An expert in embedded system security and IoT device management, Stenberg routinely shares his insights at industry technology conferences, including Embedded World, Embedded Linux Conference, Internet of Things World, Embedded Systems Conference, and other sector-focused events like automotive. He also leads efforts with key AI partners and customers, such as NVIDIA for enabling device management of physical AI systems. Stengberg is routinely featured in industry publications, including Embedded.com, Cyber Defense Magazine, InfoSecurity Watch, and Embedded Computing Design. In addition to his speaking engagements, interviews, and podcast appearances, Stenberg’s authorship includes “Distributing a Private Key Generator in Ad Hoc Networks” and publications in the Linux Journal. Stenberg holds a Master’s Degree in Mathematics with a focus on cryptography from the University of Tromsø, Norway.

Robert Daigle is the Director of Global AI Business at Lenovo, where he leads the company’s worldwide artificial intelligence strategy, business development, and go-to-market initiatives. With over a decade of experience in AI and data science, Daigle has been instrumental in scaling AI solutions across various industries, from startups to Fortune 200 companies. At Lenovo, Daigle spearheaded the launch of the AI Innovators program, fostering a network of over 45 partners and delivering more than 150 AI solutions. He also played a key role in establishing Lenovo’s first global AI Center of Excellence, supporting customer projects and proofs of concept. Under his leadership, Lenovo has developed AI-first product requirements for over 80 AI-ready platforms and introduced comprehensive AI service offerings.

Cary Bleasdale is a 13 year veteran of the medical device regulatory space and a consultant for both the Fortune 100 and startups. With over a decade of experience in working with the FDA, he is also an expert in worldwide regulatory affairs, with a focus on the EU. His background includes a decade of work with SaMD and AI medical devices. These include, most recently, AI models used for targeted molecular biotherapy. His company, James & Thomas Meditech Consulting, offers regulatory strategy and submission support.